DE69315827D1 - Neue acylierte phospholipid-arzneimittel - Google Patents

Neue acylierte phospholipid-arzneimittel

Info

Publication number
DE69315827D1
DE69315827D1 DE69315827T DE69315827T DE69315827D1 DE 69315827 D1 DE69315827 D1 DE 69315827D1 DE 69315827 T DE69315827 T DE 69315827T DE 69315827 T DE69315827 T DE 69315827T DE 69315827 D1 DE69315827 D1 DE 69315827D1
Authority
DE
Germany
Prior art keywords
carbon atoms
hydrogen
hydrocarbyl
chain
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69315827T
Other languages
English (en)
Other versions
DE69315827T2 (de
Inventor
Charles Pidgeon
Robert Markovich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp Technologies Inc
Original Assignee
Research Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp Technologies Inc filed Critical Research Corp Technologies Inc
Publication of DE69315827D1 publication Critical patent/DE69315827D1/de
Application granted granted Critical
Publication of DE69315827T2 publication Critical patent/DE69315827T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/117Esters of phosphoric acids with cycloaliphatic alcohols

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69315827T 1992-04-16 1993-04-16 Neue acylierte phospholipid-arzneimittel Expired - Fee Related DE69315827T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/869,697 US6602861B1 (en) 1992-04-16 1992-04-16 Acylated phospholipid drugs
PCT/US1993/003650 WO1993021191A1 (en) 1992-04-16 1993-04-16 Novel acylated phospholipid drugs

Publications (2)

Publication Number Publication Date
DE69315827D1 true DE69315827D1 (de) 1998-01-29
DE69315827T2 DE69315827T2 (de) 1998-07-16

Family

ID=25354097

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69315827T Expired - Fee Related DE69315827T2 (de) 1992-04-16 1993-04-16 Neue acylierte phospholipid-arzneimittel

Country Status (7)

Country Link
US (2) US6602861B1 (de)
EP (1) EP0636134B1 (de)
AT (1) ATE161261T1 (de)
CA (1) CA2133444A1 (de)
DE (1) DE69315827T2 (de)
ES (1) ES2112421T3 (de)
WO (1) WO1993021191A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859052A (en) * 1993-01-14 1999-01-12 G. D. Searle & Co. Fatty acid analogs and prodrugs
US5599947A (en) * 1993-01-14 1997-02-04 G. D. Searle & Co. Fatty acid analogs and prodrugs
US7135584B2 (en) 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
WO1996006620A2 (en) 1994-08-29 1996-03-07 Wake Forest University Lipid analogs for treating viral infections
US6350472B1 (en) * 1998-12-14 2002-02-26 Steinbach, Pylant, And Hermann, L.L.C. Method of treating HIV infection with transdermal gel containing mammalian liver extract
EP1144420B1 (de) * 1999-01-15 2003-12-10 Board Of Trustees Of The University Of Illinois Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
US7026469B2 (en) 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
AU2003203034A1 (en) * 2002-01-14 2003-07-30 Vertex Pharmaceuticals Incorporated Mucin immobilized chromatography
RU2331649C2 (ru) 2002-06-20 2008-08-20 Ай-Си Ви-И-Си Лимитед Серосодержащие фосфолипидные производные, содержащая их фармацевтическая композиция, их применение для лечения заболеваний и способ их получения
AU2004206953A1 (en) * 2003-01-22 2004-08-05 Encore Pharmaceuticals, Inc. Fat substitutes
EP2242495A2 (de) * 2008-01-16 2010-10-27 Technion Research and Development Foundation, Ltd. Verwendung antimikrobieller polymere zur resensibilisierung von mikroorganismen nach auftreten einer resistenz gegen antimikrobielle mittel
WO2011016043A2 (en) 2009-08-06 2011-02-10 Technion Research & Development Foundation Ltd. Antibiotic drug delivery and potentiation
EP3478296A4 (de) * 2016-06-29 2020-03-25 Machavert Pharmaceuticals LLC Phospholipidzusammensetzungen
KR20210005190A (ko) * 2018-04-27 2021-01-13 가부시키가이샤 레오로지 키노쇼쿠힝겐큐죠 신규 플라스말로젠 유도체

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4471113A (en) 1982-02-03 1984-09-11 The United States Of America As Represented By The Department Of Energy Prodrugs based on phospholipid-nucleoside conjugates
US5059591B1 (en) 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
JPS608948A (ja) * 1983-06-29 1985-01-17 Fujitsu Ltd 動作モ−ド検査方式
US4594193A (en) * 1984-09-26 1986-06-10 Research Corporation Thiol based lipids and membranes made therefrom
US4569794A (en) 1984-12-05 1986-02-11 Eli Lilly And Company Process for purifying proteins and compounds useful in such process
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
JPH068302B2 (ja) 1986-03-04 1994-02-02 財団法人生産開発科学研究所 重合性リン脂質化合物
DE3638687A1 (de) * 1986-11-13 1988-05-19 Lentia Gmbh Einstufiges verfahren zur herstellung von gemischt substituierten 1,2-di-acyl-sn-glycero-3-phosphocholinen
IL84387A0 (en) 1987-11-06 1990-02-09 Rapaport Erich Pharmaceutical compositions containing a substituted phosphatide
US5151445A (en) 1988-02-03 1992-09-29 Washington University Method of inhibiting parasitic activity
US4927879A (en) 1988-02-25 1990-05-22 Purdue Research Foundation Method for solid phase membrane mimetics
US4931498A (en) 1988-02-25 1990-06-05 Purdue Research Foundation Immobilized artificial membranes
US5073571A (en) 1988-06-16 1991-12-17 Washington University Method of inhibiting virus
US5082967A (en) 1988-06-16 1992-01-21 Washington University Novel fatty acid analog enzyme substrates
DE3929217A1 (de) 1989-09-02 1991-03-07 Boehringer Mannheim Gmbh Verwendung von phospholipid-derivaten als antivirale arzneimittel und neue phospholipide
SE463789B (sv) 1990-03-27 1991-01-21 Henrik Gerhard Renvall Saett att registrera, oeverfoera och lagra information med hjaelp av streckkoder
US5149527A (en) * 1990-09-18 1992-09-22 Oncotech, Inc. Immunopotentiating protocol for chemotherapy-responsive tumors

Also Published As

Publication number Publication date
ATE161261T1 (de) 1998-01-15
US5846955A (en) 1998-12-08
WO1993021191A1 (en) 1993-10-28
US6602861B1 (en) 2003-08-05
CA2133444A1 (en) 1993-10-28
EP0636134A1 (de) 1995-02-01
EP0636134B1 (de) 1997-12-17
ES2112421T3 (es) 1998-04-01
DE69315827T2 (de) 1998-07-16

Similar Documents

Publication Publication Date Title
DE69315827T2 (de) Neue acylierte phospholipid-arzneimittel
PH17740A (en) Substituted acyl derivatives of 1-2,3,4 tetrahydro-isoquinoline-3-carboxylic acids,their pharmaceutical compositions and use
FI87762C (fi) Fenylnaftalenderivat och kosmetiska kompositioner innehaollande dessa derivat
ATE226821T1 (de) Verwendung von langkettigen n-alkyl derivaten von deoxynojirimycin zur herstellung eines medikaments zur behandlung von mit glykolipiden akkumulation zusammenhängenden krankheiten
SE8201854L (sv) N-substituerade amino-aminosyror
EE03999B1 (et) Fumaarhappe derivaatide kasutamine
HUT71402A (en) Use of terfenadine derivatives as antihistaminics in a hepatically impaired patient
ES2187025T3 (es) Nuevos agentes quelantes de hierro (iii) activos via oral.
EP0467856A3 (en) Aminoalkanesulfonic acid derivatives and pharmaceutical compositions for use in preventing or treating heart diseases
IL111581A (en) Cyclic amino acid derivatives pharmaceutical compositions containing them and process for their preparation
SE8204640L (sv) Aminosyraderivat
DE3463766D1 (en) Radioprotector agents with an aminothioalkyl structure, and process for their preparation
EA199800155A1 (ru) Новое соединение
DE69207479D1 (de) Verwendung der Ester von Acyl-L-Carnitin mit Gamma-Hydroxy-Buttersäure zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Lebererkrankungen
EP0228314A3 (de) Verwendung von Äthanolamin-derivaten zur Behandlung oder Prävention von Hyperlipämie
HUT62855A (en) Process for producing glycerol derivatives and pharmaceutical compositions comprising same
DK0971899T3 (da) Hexahydroindenopyridinforbindelser med antispermatogen virkning
ES2058315T3 (es) Compuestos eficaces contra insuficiencia cerebral.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee